3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow narlaprevir: new trials by email Literature Review of narlaprevir trials Research Report on narlaprevir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Drug Interaction Study to Assess the Pharmacokinetics of Narlaprevir and Antiretroviral Drugs Narlaprevir, Ritonavir, Tenofovir Disoproxil Fumarate - Healthy | Phase 1 | Completed | R-Pharm | 36 | 2017-04-24 | 2019-02-19 |
| A Pharmacokinetic Study of Narlaprevir as a Single Dose or With Ritonavir Combination in Patients With Hepatic Impairment and Healthy Matched Volunteers Narlaprevir, Ritonavir - Hepatic Impairment | Phase 1 | Completed | R-Pharm | 32 | 2013-11-08 | 2019-05-22 |
| Safety, Tolerability, PK and PD of SCH 900518 in Naive or Treatment-Experienced Subjects Infected With HCV Genotype 1 (Protocol No. P04695) Drug: SCH 900518 Biologic: Peginterferon alfa-2b(PegIntron), Drug: SCH 900518 Biologic: Peginterferon alfa-2b, Drug: SCH 900518 Drug: Ritonavir (RTV) Biologic: Peginterferon alfa-2b (PegIntron) - Hepatitis C, Chronic | Phase 1 | Completed | Merck Sharp & Dohme LLC | 41 | 2007-07-01 | 2015-02-09 |
Bronchiolitis Obliterans Syndrome (1) · Coinfection (1) · Hepatitis C (1) · Hepatitis C, Chronic (1)
R-Pharm (2) · Merck Sharp & Dohme LLC (1)
Russia (2) · Georgia (1)
Mikhail Samsonov (2)